Eugita Therapeutics Analysis
What is Eugita Therapeutics?
Eugita Therapeutics develops tissue-targeting therapies using computational genomics and immunology to create innovative treatments for various diseases.
Company Stage
Seed
Investors
- Y Combinator
YC Batch
S22
Product Features & Capabilities
- immune cell-based therapies for breast, ovarian, and prostate cancers, focus on tissue targeting, leveraging computational genomics and immunology.
Who are the founders of Eugita Therapeutics
NB
Nizar Batada
CEO/Co-Founder
YF
Yoshi Fukazawa
VP of Research / Co-Founder
GC
George Church
Scientific Advisor / Co-Founder
See something that needs updating? Suggest edits to this profile.